breastfeeding on semaglutide and Breastfeeding: Safety Facts Semaglutide and Breastfeeding | Women's

Most people will start to notice results within the first few weeks of treatment, but the most noticeable weight loss occurs after 3 to 6 months

These results were recently presented at the European Congress on Obesity (ECO) 2025 in Malaga, Spain

Injection site reactions are purely a tirzepatide concern and have nothing to do with bupropion, but they are worth mentioning because injection site reaction treatment sometimes involves anti-inflammatory medications that could interact with other drugs in your regimen

Regular follow-up every 3-6 months, assessment of fat-soluble vitamin levels if malabsorption is present, and monitoring for biliary complications are recommended

Its essential to monitor blood sugar levels and adjust medication doses accordingly under a healthcare providers guidance

When switching, always initiate at the lowest dose unless instructed otherwise by your healthcare provider